Cargando…
Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy
Acute lung injury (ALI) is a critical illness without effective therapeutic modalities currently. Recent studies indicated potential efficacy of statins for ALI, while high-dose statins was suggested to be significant for attenuating inflammation in vivo. Therefore, a lung-targeted drug delivery sys...
Autores principales: | Li, Shu-Juan, Wang, Xiao-Juan, Hu, Jing-Bo, Kang, Xu-Qi, Chen, Li, Xu, Xiao-Ling, Ying, Xiao-Ying, Jiang, Sai-Ping, Du, Yong-Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248938/ https://www.ncbi.nlm.nih.gov/pubmed/28165814 http://dx.doi.org/10.1080/10717544.2016.1259369 |
Ejemplares similares
-
Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy
por: Li, Shujuan, et al.
Publicado: (2018) -
Effective targeted therapy for drug-resistant infection by ICAM-1 antibody-conjugated TPGS modified β-Ga(2)O(3):Cr(3+) nanoparticles
por: Kang, Xu-Qi, et al.
Publicado: (2019) -
Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies
por: Mousavi-Simakani, Seyedeh Maryam, et al.
Publicado: (2023) -
Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer
por: Kebebe, Dereje, et al.
Publicado: (2019) -
Development of novel rosuvastatin nanostructured lipid carriers for oral delivery in an animal model
por: Li, Jun, et al.
Publicado: (2018)